Total Payments
$151,311
2024 Payments
$7,199
Companies
24
Transactions
680
Medicare Patients
694
Medicare Billing
$99,982
Payment Breakdown by Category
Other$114,527 (75.7%)
Food & Beverage$17,570 (11.6%)
Travel$16,344 (10.8%)
Consulting$2,800 (1.9%)
Education$69.41 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $114,412 | 70 | 75.6% |
| Food and Beverage | $17,570 | 560 | 11.6% |
| Travel and Lodging | $16,344 | 44 | 10.8% |
| Consulting Fee | $2,800 | 2 | 1.9% |
| Entertainment | $115.46 | 1 | 0.1% |
| Education | $69.41 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $138,218 | 232 | $0 (2024) |
| ViiV Healthcare Company | $4,550 | 166 | $0 (2024) |
| Gilead Sciences, Inc. | $2,579 | 85 | $0 (2024) |
| Theratechnologies Inc. | $1,203 | 31 | $0 (2024) |
| Novo Nordisk Inc | $987.82 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $883.68 | 46 | $0 (2023) |
| Merck Sharp & Dohme LLC | $839.38 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $607.67 | 12 | $0 (2024) |
| Janssen Products, LP | $391.95 | 5 | $0 (2023) |
| Napo Pharmaceuticals Inc | $246.00 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,199 | 97 | ABBVIE INC. ($4,267) |
| 2023 | $11,155 | 92 | AbbVie Inc. ($9,610) |
| 2022 | $11,518 | 110 | ABBVIE INC. ($9,578) |
| 2021 | $7,556 | 101 | AbbVie Inc. ($5,477) |
| 2020 | $31,137 | 89 | AbbVie Inc. ($29,871) |
| 2019 | $62,508 | 110 | AbbVie, Inc. ($60,889) |
| 2018 | $19,008 | 57 | AbbVie, Inc. ($18,325) |
| 2017 | $1,230 | 24 | Gilead Sciences Inc ($328.06) |
All Payment Transactions
680 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: HIV | ||||||
| 12/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,875.00 | General |
| Category: VIROLOGY | ||||||
| 12/17/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: HIV | ||||||
| 12/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: VIROLOGY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $119.41 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $33.17 | General |
| Category: HIV | ||||||
| 11/27/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: HIV | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.14 | General |
| 11/20/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Neurology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $112.37 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.19 | General |
| 11/12/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $115.93 | General |
| Category: VIROLOGY | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/29/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: HIV | ||||||
| 10/24/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.05 | General |
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: HIV | ||||||
| 10/04/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: HIV | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $30.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Neuropsychiatry | ||||||
| 09/27/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $103.33 | General |
| 09/27/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $71.28 | General |
| 09/27/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $51.73 | General |
| 09/27/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $27.59 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 243 | 571 | $57,540 | $33,610 |
| 2022 | 4 | 191 | 510 | $47,101 | $25,522 |
| 2021 | 5 | 160 | 347 | $42,825 | $24,325 |
| 2020 | 3 | 100 | 239 | $35,280 | $16,524 |
Total Patients
694
Total Services
1,667
Medicare Billing
$99,982
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 282 | $40,890 | $22,573 | 55.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 26 | 26 | $4,550 | $3,989 | 87.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 64 | $6,400 | $3,944 | 61.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 78 | 185 | $1,850 | $1,554 | 84.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $3,850 | $1,551 | 40.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 294 | $42,630 | $23,522 | 55.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 25 | $2,500 | $1,431 | 57.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 76 | 178 | $1,780 | $526.50 | 29.6% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 13 | 13 | $191.00 | $42.12 | 22.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 230 | $33,350 | $20,022 | 60.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 25 | $4,375 | $1,803 | 41.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $3,150 | $1,542 | 49.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $1,300 | $763.40 | 58.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 41 | 65 | $650.00 | $195.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 56 | 176 | $25,455 | $10,785 | 42.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 47 | $8,225 | $4,830 | 58.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 16 | $1,600 | $909.18 | 56.8% |
About Dr. Robert Wallace, MD
Dr. Robert Wallace, MD is a Family Medicine healthcare provider based in St Petersburg, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2011. The National Provider Identifier (NPI) number assigned to this provider is 1821396151.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Wallace, MD has received a total of $151,311 in payments from pharmaceutical and medical device companies, with $7,199 received in 2024. These payments were reported across 680 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($114,412).
As a Medicare-enrolled provider, Wallace has provided services to 694 Medicare beneficiaries, totaling 1,667 services with total Medicare billing of $99,982. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location St Petersburg, FL
- Active Since 03/10/2011
- Last Updated 07/24/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821396151
Products in Payments
- Mavyret (Drug) $64,710
- MAVYRET (Drug) $47,431
- DOVATO (Drug) $1,919
- SYMTUZA (Drug) $1,001
- EGRIFTA (Drug) $705.28
- CABENUVA (Biological) $605.92
- APRETUDE (Biological) $555.83
- TROGARZO (Drug) $497.38
- Ozempic (Drug) $465.88
- AIRSUPRA (Drug) $449.90
- PIFELTRO (Drug) $436.57
- Rybelsus (Drug) $335.99
- ISENTRESS (Drug) $254.18
- Mytesi (Drug) $246.00
- Biktarvy (Drug) $243.00
- TRIUMEQ (Drug) $226.80
- Epclusa (Drug) $225.40
- JULUCA (Drug) $224.77
- TIVICAY (Drug) $222.64
- VRAYLAR (Drug) $185.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in St Petersburg
Edward Braun, Md, MD
Family Medicine — Payments: $329,209
Family Medicine $329,209
Dr. Roxana Stoici, Md, MD
Family Medicine — Payments: $228,936
Family Medicine $228,936
Dr. Frederic Guerrier, M.d, M.D
Family Medicine — Payments: $45,706
Family Medicine $45,706
Dr. Gigi Lefebvre, Md, MD
Family Medicine — Payments: $15,802
Family Medicine $15,802
Dr. Daniel Eckstein, M.d, M.D
Family Medicine — Payments: $10,665
Family Medicine $10,665
Dr. Kunal Amin, Md, MD
Family Medicine — Payments: $10,623
Family Medicine $10,623